APOBEC3B and breast cancer: In a study we performed earlier, we observed higher mRNA levels of APOBEC3B in breast cancer metastasis as compared to the corresponding primary tumor [14], supporting our hypothesis that, already starting from DCIS, breast cancer progression is associated with deregulated expression of APOBEC3B.